UCM-13207

CAT: 0804-HY-149708-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-149708-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
UCM-13207 (compound 21) is a selective ICMT inhibitor that ameliorates basic progeria-like features. UCM-13207 can improve the survival rate of LmnaG609G/G609G mice in the mouse premature aging model[1].
CAS Number
[1621536-10-4]
UNSPSC
12352005
Target
ICMT
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ucm-13207.html
Purity
99.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(CCN(CCCCCCCC)C(C1=CC=CC=C1)=O)NC2=CC=CC=C2
Molecular Formula
C24H32N2O2
Molecular Weight
380.52
References & Citations
[1]Marcos-Ramiro B et al. Isoprenylcysteine carboxylmethyltransferase-based therapy for Hutchinson–Gilford progeria syndrome[J]. ACS Central Science, 2021, 7 (8) : 1300-1310.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-162265UCM-13369
HY-155954-01UCM-1336
HY-115304UCM 793
HY-101074-01UCM 608
HY-119010UCM 549
HY-167862UCM-05194
HY-179573UCM-A86
HY-148867-01UCM-1306
HY-167862AUCM-05194 (ammonium)
HY-101074RUCM 608 (Standard)

Alternative Products

CatalogName
MF-0099875-01UCM-13207
M35941-01UCM-1306
MBS5786639UCM-1336
MBS5784466UCM 793
B6901-10UCM 707
MF-0152255UCM 454
MF-0098411-01UCM-05194
MF-0048409UCM 724
MF-0052579-01UCM 765
BUP05717-01UCM 608

Popular Products